CHARLES ANDREW YOUNG
Pilots at End Ave, New York, NY
License number
New York A4202690
Issued Date
Apr 2016
Expiration Date
Apr 2017
Category
Airmen
Type
Authorized Aircraft Instructor
Address
Address
33 E End Ave, New York, NY 10028
Professional information
Information Technology Manager At Somerset Hills School District
Position:
Information Technology Manager at Somerset Hills School District
Location:
Greater New York City Area
Industry:
Information Technology and Services
Work:
Somerset Hills School District
- Bernardsville, NJ since May 2008
-
Information Technology Manager
Wyalusing Area School District
- Wyalusing, PA 2004 - May 2008
-
Director of Technology
University of Scranton
- Scranton, PA 2000 - 2003
-
Instructional Technologist
University of Scranton
- Scranton, PA 1998 - 2000
-
Technology Training Coordinator
Chamberlain Manufacturing (General Dynamics)
- Scranton, PA 1996 - 1998
-
Information Technology Specialist
Education:
Wilkes University 2005 - 2006
Master of Education (M.Ed.), Instructional Technology University of Scranton 1992 - 1996
Bachelors of Science, Computer Information Systems
Master of Education (M.Ed.), Instructional Technology University of Scranton 1992 - 1996
Bachelors of Science, Computer Information Systems
Interests:
Reading, Traveling, Music, Outdoors
Samsung It Field Marketing Representative At Premium Retail Services
Position:
Samsung IT Field Marketing Representative at Premium Retail Services
Location:
Greater New York City Area
Industry:
Consumer Services
Work:
Premium Retail Services
since May 2011
-
Samsung IT Field Marketing Representative
Acclivity, LLC.
Jan 2008 - Feb 2009
-
Marcom Support Specialist
Acclivity LLC
Nov 2005 - Jan 2008
-
Technical Support Representative
Allied Building Products
Aug 2003 - Nov 2005
-
Data Services
Physicians World
Sep 2001 - Jun 2002
-
Speakers Bureau Representative
Education:
County College of Morris 1997 - 1999
AS, Public Administration (Maj.) - Journalism (Min.) Morris Hills High School 1993 - 1997
Diploma
AS, Public Administration (Maj.) - Journalism (Min.) Morris Hills High School 1993 - 1997
Diploma
Skills:
Customer Service, Marketing Communications, Marketing, Coaching, Microsoft Office, Team Management, Training
Teacher At Neptune Township Board Of Education
Position:
Teacher at Neptune Township Board of Education
Location:
Greater New York City Area
Industry:
Education Management
Work:
Neptune Township Board of Education
-
Teacher
Education:
Brown University 1967 - 1971
Bachelor of Arts (B.A.), English Language and Literature, General Rutgers, The State University of New Jersey-New Brunswick 1971 - 1974
MAT, English Education
Bachelor of Arts (B.A.), English Language and Literature, General Rutgers, The State University of New Jersey-New Brunswick 1971 - 1974
MAT, English Education
Charles Young, New York NY
Work:
Associate Ophthalmologist
150 Broadway, New York, NY 10038
150 Broadway, New York, NY 10038
Independent Aviation &Amp; Aerospace Professional
Position:
Photographer at The Society of Connecticut Sculptors
Location:
Greater New York City Area
Industry:
Aviation & Aerospace
Work:
The Society of Connecticut Sculptors
since Jan 1998
-
Photographer
Transportation/Trucking/Railroad Professional
Location:
Greater New York City Area
Industry:
Transportation/Trucking/Railroad
Use Of Somatostatin Receptor Agonists In The Treatment Of Human Disorders Of Sleep Hypoxia And Oxygen Deprivation
US Patent:
2003008, May 1, 2003
Filed:
Oct 25, 2002
Appl. No.:
10/280517
Inventors:
Charles Young - New York NY, US
International Classification:
A61K038/12
US Classification:
514/009000
Abstract:
The invention relates to a method of treating diverse human disorders that may arise, in part, out of sleep hypoxia and oxygen deprivation occurring in the context of sleep apnea/hypopnea disturbances. The disorders that may be treated by the invention comprise gastroesophageal reflux disease (GERD), asthma-associated gastroesophageal reflux (GER), GER-associated asthma, asthma, cardiomyopathy, cardioarrhythmia, congestive heart failure, sudden infant death syndrome, and diverse neurologic conditions. The mode of treatment uses somatostatin receptor ligands (SstRLs), particularly somatostatin-receptor agonists. The invention concerns the method of treatment utilizing, and compositions comprising SstRLs and somatostatin receptor agonists, including agonists of the somatostatin receptor types 2 and 5, particularly, the type 2A receptor (SsR-2A), including octreotide and lanreotide.
Methods For Inhibiting The Proliferation Of Brain And Hepatic Metastases By Using Lonidamine
US Patent:
5260327, Nov 9, 1993
Filed:
Aug 4, 1992
Appl. No.:
7/925813
Inventors:
Jae H. Kim - West Bloomfield MI
Sang H. Kim - Flushing NY
Alan Alfieri - Garden City NY
Charles W. Young - New York NY
Sang H. Kim - Flushing NY
Alan Alfieri - Garden City NY
Charles W. Young - New York NY
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A61K 31415, A61K 3111
US Classification:
514405
Abstract:
This invention provides methods for inhibiting the proliferation of brain or hepatic metastases, in vivo, by contacting the cells with lonidamine and radiation.
Modified Adenovirus And Uses Thereof
US Patent:
2002010, Aug 8, 2002
Filed:
Jul 13, 2001
Appl. No.:
09/904669
Inventors:
Charles Young - New York NY, US
Peter Hoey - Belle Harbor NY, US
Peter Hoey - Belle Harbor NY, US
International Classification:
C12Q001/70, C12P019/34, A61K048/00, A01N063/00, A61K039/12, A61K039/23, A61K039/235
US Classification:
424/233100, 424/199100, 424/093200, 435/091330, 435/005000
Abstract:
The present invention provides a modified adenovirus comprising genomic adenoviral DNA which has been modified so that (i) the only gene product of the early region (E4) that is expressed is open reading frame (ORF-6), (ii) neither the gene product of the E1A region nor the gene product of the E1B region is expressed, and (iii) no other early or late gene products are expressed. The present invention also provides methods of inhibiting repair of breaks in double-stranded DNA in a cell, preventing concatamerization of linear wild-type adenoviral DNA, inhibiting V(D)J recombination of nucleic acid sequences encoding immunoglobulins, preventing apoptosis, and preventing and treating cancer.
Independent Venture Capital &Amp; Private Equity Professional
Location:
Greater New York City Area
Industry:
Venture Capital & Private Equity